{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:17:02Z","timestamp":1773991022763,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10198-020-01220-w","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T15:34:26Z","timestamp":1601652866000},"page":"1363-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas"],"prefix":"10.1007","volume":"21","author":[{"given":"Richard Huan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza Lai Yi","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-6472","authenticated-orcid":false,"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"1220_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1472-6963-14-170","volume":"14","author":"N Tantai","year":"2014","unstructured":"Tantai, N., Chaikledkaew, U., Tanwandee, T., et al.: A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand. BMC Health Serv Res 14, 170 (2014). https:\/\/doi.org\/10.1186\/1472-6963-14-170","journal-title":"BMC Health Serv Res"},{"key":"1220_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-019-00229-6","author":"H Ameri","year":"2019","unstructured":"Ameri, H., Yousefi, M., Yaseri, M., et al.: Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in colorectal cancer patients. J Gastrointest Cancerd (2019). https:\/\/doi.org\/10.1007\/s12029-019-00229-6","journal-title":"J Gastrointest Cancerd"},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1477-7525-12-35","volume":"12","author":"I Proskorovsky","year":"2014","unstructured":"Proskorovsky, I., Lewis, P., Williams, C., et al.: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health Qual Life Outcomes 12, 35 (2014). https:\/\/doi.org\/10.1186\/1477-7525-12-35","journal-title":"Health Qual Life Outcomes"},{"key":"1220_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","volume":"11","author":"J Brazier","year":"2010","unstructured":"Brazier, J., Yang, Y., Tsuchiya, A., et al.: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Heal Econ Prev Care 11, 215\u2013225 (2010). https:\/\/doi.org\/10.1007\/s10198-009-0168-z","journal-title":"Heal Econ Prev Care"},{"key":"1220_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jval.2018.06.006","volume":"21","author":"LA Gray","year":"2018","unstructured":"Gray, L.A., Wailoo, A.J., Hernandez, A.M.: Mapping the FACT-B instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response mapping. Value Heal 21, 1399\u20131405 (2018). https:\/\/doi.org\/10.1016\/j.jval.2018.06.006","journal-title":"Value Heal"},{"key":"1220_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15587497","author":"TA Young","year":"2015","unstructured":"Young, T.A., Mukuria, C., Rowen, D., et al.: Mapping functions in health-related quality of life : mapping from two quality-of-life instruments to EQ-5D-3L. Med Decis Mak (2015). https:\/\/doi.org\/10.1177\/0272989X15587497","journal-title":"Med Decis Mak"},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jval.2012.10.010","volume":"16","author":"L Longworth","year":"2013","unstructured":"Longworth, L., Rowen, D.: Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Heal 16, 202\u2013210 (2013). https:\/\/doi.org\/10.1016\/j.jval.2012.10.010","journal-title":"Value Heal"},{"key":"1220_CR8","unstructured":"Tolley K, Morgan G, Cartwright R et al (1998) Economic aspects of Non-Hodgkin\u2019s Lymphoma. https:\/\/www.ohe.org\/publications\/economic-aspects-non-hodgkins-lymphoma. Accessed 17 Sept 2020"},{"key":"1220_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1553-9","volume":"16","author":"S Lamy","year":"2016","unstructured":"Lamy, S., Bettiol, C., Grosclaude, P., et al.: The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study. BMC Health Serv Res 16, 1\u201310 (2016). https:\/\/doi.org\/10.1186\/s12913-016-1553-9","journal-title":"BMC Health Serv Res"},{"key":"1220_CR10","unstructured":"International agency for research on cancer (IARC). https:\/\/www.iarc.fr\/. Accessed 17 Sept 2020"},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ijc.1439","volume":"94","author":"M Kyriaki","year":"2001","unstructured":"Kyriaki, M., Eleni, T., Efi, P., et al.: The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample. Int J cancer 94, 135\u2013139 (2001)","journal-title":"Int J cancer"},{"key":"1220_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20, 1727\u20131736 (2011). https:\/\/doi.org\/10.1007\/s11136-011-9903-x","journal-title":"Qual Life Res"},{"key":"1220_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1586\/14737167.2013.850420","volume":"13","author":"H Mctaggart-Cowan","year":"2013","unstructured":"Mctaggart-Cowan, H., Teckle, P., Peacock, S.: Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature. Expert Rev Pharmacoecon Outcomes Res 13, 753\u2013765 (2013). https:\/\/doi.org\/10.1586\/14737167.2013.850420","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0272989X11427761","volume":"32","author":"MM Versteegh","year":"2012","unstructured":"Versteegh, M.M., Leunis, A., Luime, J.J., et al.: Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Med Decis Mak 32, 554\u2013568 (2012). https:\/\/doi.org\/10.1177\/0272989X11427761","journal-title":"Med Decis Mak"},{"key":"1220_CR15","unstructured":"Van Reenen M, Janssen B (2015) EQ-5D-5L User Guide - Basic information on how to use the EQ-5D-5L instrument. Version 2.1. EuroQol Research Foundation"},{"key":"1220_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo, N., Liu, G., Li, M., et al.: Estimating an EQ-5D-5L value set for China. Value Heal 20, 662\u2013669 (2017). https:\/\/doi.org\/10.1016\/j.jval.2016.11.016","journal-title":"Value Heal"},{"key":"1220_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-1036-2","author":"Z Yang","year":"2018","unstructured":"Yang, Z., Busschbach, J., Liu, G., et al.: EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes (2018). https:\/\/doi.org\/10.1186\/s12955-018-1036-2","journal-title":"Health Qual Life Outcomes"},{"key":"1220_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N.K., Ahmedzai, S., Bergman, B., et al.: The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85, 365 (1993). https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"1220_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s41669-017-0027-2","volume":"1","author":"J Round","year":"2017","unstructured":"Round, J., Hawton, A.: Statistical alchemy: conceptual validity and mapping to generate health state utility values. Pharmacoecono Open 1, 233\u2013239 (2017). https:\/\/doi.org\/10.1007\/s41669-017-0027-2","journal-title":"Pharmacoecono Open"},{"key":"1220_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10198-019-01088-5","volume":"20","author":"F Yang","year":"2019","unstructured":"Yang, F., Wong, C.K.H., Luo, N., et al.: Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis. Eur J Heal Econ 20, 1195 (2019). https:\/\/doi.org\/10.1007\/s10198-019-01088-5","journal-title":"Eur J Heal Econ"},{"key":"1220_CR21","volume-title":"Scale development : theory and applications","author":"RF DeVellis","year":"2017","unstructured":"DeVellis, R.F.: Scale development : theory and applications, 4th edn. SAGE, Los Angeles (2017)","edition":"4"},{"key":"1220_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0857-3","author":"H Dakin","year":"2018","unstructured":"Dakin, H., Abel, L., Burns, R., et al.: Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Heal Qual Life Outcomes (2018). https:\/\/doi.org\/10.1186\/s12955-018-0857-3","journal-title":"Heal Qual Life Outcomes"},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-7525-7-27","volume":"7","author":"D Rowen","year":"2009","unstructured":"Rowen, D., Brazier, J., Roberts, J.: Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 7, 27 (2009). https:\/\/doi.org\/10.1186\/1477-7525-7-27","journal-title":"Health Qual Life Outcomes"},{"key":"1220_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jval.2017.09.017","volume":"21","author":"LA Gray","year":"2018","unstructured":"Gray, L.A., Hern\u00e1ndez Alava, M., Wailoo, A.J.: Development of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in patients with asthma. Value Heal 21, 748\u2013757 (2018). https:\/\/doi.org\/10.1016\/j.jval.2017.09.017","journal-title":"Value Heal"},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10198-013-0559-z","volume":"16","author":"M Wu","year":"2014","unstructured":"Wu, M., Brazier, J.E., Kearns, B., et al.: Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. Eur J Heal Econ 16, 141\u2013151 (2014). https:\/\/doi.org\/10.1007\/s10198-013-0559-z","journal-title":"Eur J Heal Econ"},{"key":"1220_CR26","doi-asserted-by":"crossref","unstructured":"Gray LA, Alava MH (2018) A command for fitting mixture regression models for bounded dependent variables using the beta distribution. Stata J 18:51\u201375","DOI":"10.1177\/1536867X1801800105"},{"key":"1220_CR27","doi-asserted-by":"crossref","unstructured":"Alava MH, Wailoo A (2015) Fitting adjusted limited dependent variable mixture models to EQ-5D. Stata J 15:737\u201350","DOI":"10.1177\/1536867X1501500307"},{"key":"1220_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/09286586.2014.888456","volume":"21","author":"S Kay","year":"2014","unstructured":"Kay, S., Ferreira, A.: Mapping the 25-item national eye institute visual functioning questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol 21, 66\u201378 (2014). https:\/\/doi.org\/10.3109\/09286586.2014.888456","journal-title":"Ophthalmic Epidemiol"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"e0175847","DOI":"10.1371\/journal.pone.0175847","volume":"12","author":"CKH Wong","year":"2017","unstructured":"Wong, C.K.H., Cheung, P.W.H., Samartzis, D., et al.: Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis. PLoS ONE 12, e0175847 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0175847","journal-title":"PLoS ONE"},{"key":"1220_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1524-4733.2008.00352.x","volume":"11","author":"R Ara","year":"2008","unstructured":"Ara, R., Brazier, J.: Deriving an Algorithm To Convert The Eight Mean SF-36 dimension scores into a mean eq-5d preference-based score from published studies (where patient level data are not available). Value Heal 11, 1131\u20131143 (2008). https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00352.x","journal-title":"Value Heal"},{"key":"1220_CR31","volume-title":"Data analysis : a model comparison approach","author":"CM Judd","year":"2009","unstructured":"Judd, C.M.: Data analysis : a model comparison approach, 2nd edn. Routledge, New York (2009)","edition":"2"},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10198-010-0233-7","volume":"11","author":"R Crott","year":"2010","unstructured":"Crott, R., Briggs, A.: Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. Heal Econ Prev Care 11, 427\u2013434 (2010). https:\/\/doi.org\/10.1007\/s10198-010-0233-7","journal-title":"Heal Econ Prev Care"},{"key":"1220_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jval.2011.04.003","volume":"14","author":"RL Askew","year":"2011","unstructured":"Askew, R.L., Swartz, R.J., Xing, Y., et al.: Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Heal 14, 900\u2013906 (2011). https:\/\/doi.org\/10.1016\/j.jval.2011.04.003","journal-title":"Value Heal"},{"key":"1220_CR34","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/JTO.0b013e3181f77a6a","volume":"5","author":"RW Jang","year":"2010","unstructured":"Jang, R.W., Isogai, P.K., Mittmann, N., et al.: Derivation of utility values from european organization for research and treatment of cancer quality of life-core 30 questionnaire values in lung cancer. J Thorac Oncol 5, 1953\u20131957 (2010). https:\/\/doi.org\/10.1097\/JTO.0b013e3181f77a6a","journal-title":"J Thorac Oncol"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-020-01220-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-020-01220-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-020-01220-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T23:31:55Z","timestamp":1632267115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-020-01220-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s10198-020-01220-w","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}